Unknown OBSERVATIONAL NCT03809247

Microbial Diversity of Pancreatic Diseases

Sponsor: Ruijin Hospital

Conditions Pancreatic Cancer Pancreatic Disease

Updated 9 times since 2019 Last updated: Jun 13, 2023 Started: Feb 1, 2019 Primary completion: Jul 30, 2024 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Pancreatic Cancer and Pancreatic Disease and is currently ongoing. Ruijin Hospital leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

9 versions recorded

Feb 2026 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jul 2023 — Jul 2024 [monthly]

Recruiting
Feb 2022 — Jul 2023 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 4 earlier versions

Dec 2021 — Feb 2022 [monthly]

Not Yet Recruiting
Jan 2021 — Dec 2021 [monthly]

Not Yet Recruiting
Nov 2020 — Jan 2021 [monthly]

Not Yet Recruiting
Feb 2019 — Nov 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ruijin Hospital

Data source: Ruijin Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China